We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOTK:NASDAQSono-Tek Corporation Analysis

Data as of 2026-05-02 - not real-time

$5.18

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sono‑Tek’s stock is technically bullish, trading at $5.18 well above its 20‑day ($4.35), 50‑day ($4.20) and 200‑day ($4.03) simple moving averages, with a bullish MACD crossover and an RSI of 68.7 indicating strong momentum but approaching overbought territory. Volume is on the rise, the beta of 0.45 suggests limited market‑wide volatility, yet the 30‑day price volatility of over 57% and an “Extreme Greed” sentiment index point to heightened short‑term risk. The price sits near the $5.70 resistance level, supported by a $3.86 floor, and recent news cites “stronger visibility growth and renewed competitive positioning,” which could underpin a push toward the analyst‑derived target of $6.75.
Fundamentally, the company posted $20.4 M in revenue but saw a 3.6% decline year‑over‑year, and while gross margins hover near 50%, operating margins are thin at 6.4% and cash flow is negative. The balance sheet is solid with $11.7 M of cash and zero debt, yet the trailing P/E of 51.8 versus an industry average of 38.5, a P/B of 4.25, and the absence of dividends signal an overvalued position. Negative operating and free cash flow, coupled with modest ROE (8.6%), temper enthusiasm despite the upside potential implied by the target price.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near resistance with high RSI
  • Bullish MACD and increasing volume
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Target price suggests ~30% upside
  • Revenue decline and negative cash flow
  • Strong cash balance and zero debt

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • High valuation multiples relative to peers
  • Sustained earnings and cash‑flow weakness
  • Limited dividend return and modest growth outlook

Key Metrics & Analysis

Financial Health

Revenue Growth-3.60%
Profit Margin7.72%
P/E Ratio51.8
ROE8.63%
ROA3.91%
P/B Ratio4.3
Op. Cash Flow$-564638
Free Cash Flow$-1432027
Industry P/E38.5

Technical Analysis

TrendBullish
RSI68.7
Support$3.86
Resistance$5.70
MA 20$4.35
MA 50$4.20
MA 200$4.03
MACDBullish
VolumeIncreasing
Fear & Greed Index91.09

Valuation

Target Price$6.75
Upside/Downside30.31%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.45
Volatility57.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.